No Results
"We are currently gathering more data to assess the safety of torreya.com. Your safety is our priority, and we're conducting a thorough analysis before providing a comprehensive evaluation."
Torreya is a global investment banking boutique providing mergers and acquisitions, capital markets, and licensing advisory services to life sciences companies. Since our inception in 2007, we have advised on more than $100 billion worth of deals for clients in the biotechnology, branded pharmaceutical, generic pharmaceutical, and life sciences sectors.
Traffic rank of torreya.com, compared to all other sites
↓ 6.05M+
Website ranking is crucial for evaluating torreya.com's stats. TopWeb.ai leverages cutting-edge techniques, including data gathering, collection, and analysis from diverse internet resources, to estimate website traffic. Our assessments are based solely on publicly available information, offering valuable insights into potential traffic trends without relying on business owner-provided data. Additionally, we utilize advanced tools like ChatGPT and Gemini API to enhance our evaluation process, ensuring accurate and comprehensive traffic estimations and analysis.
Over the last three months, torreya.com's global ranking has decreased from 9,832,014 to 15,884,731.
Total Visits
Bounce Rate
Pages per Visit
Avg Visit Duration
Moz metrics are by Moz that predicts how well a specific page will rank.
WOT's security score derives from our partners and community-driven expert reviews
Amazon Alexa Rank provides a broad gauge of a website's online popularity.
The Organic Search section reveals valuable insights, including organic traffic and keywords for in Google's top 100 search results.
Explore alternative, competitive and similar websites to torreya.com based on traffic, content and site structure.
EFPIA Homepage.
Efpia alternatives
Pharmashots alternatives
Pharmaventures alternatives
Plg-group alternatives
Cortellis - Clarivate Analytics.
Cortellis alternatives
Unryudo alternatives
BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer.
Beigene alternatives
Pharmchoices alternatives
Capital-drug alternatives
Cell-innovator alternatives
Check out some of our popular sites.